Ignite Creation Date:
2024-05-06 @ 2:47 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04421378
Status:
TERMINATED
Last Update Posted:
2023-09-06
First Post:
2020-06-01
Brief Title:
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Karyopharm Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Glioblastoma Multiforme |